FTSE MIB
33.812,44 +41,37 (+0,12%) Dow Jones
40.589,34 +654,27 (+1,64%) Nasdaq
17.357,88 +176,16 (+1,03%) Nikkei 225
37.667,41 -202,10 (-0,53%) Petrolio
76,44 -1,84 (-2,35%) Bitcoin EUR
62.555,20 +840,04 (+1,36%)
Stereotaxis, Inc. (STXS)
Dopo ore:
| Chiusura precedente | 2,0400 |
| Aperto | 2,0600 |
| Denaro | 2,0000 x 800 |
| Domanda | 2,0700 x 800 |
| Min-Max giorno | 1,9800 - 2,0600 |
| Intervallo di 52 settimane | 1,3300 - 3,2900 |
| Volume | |
| Media Volume | 374.967 |
| Capitalizzazione | 170,245M |
| Beta (mensile su 5 anni) | 1,51 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,2600 |
| Prossima data utili | 12 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 4,50 |
GlobeNewswireStereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will participate in the Society for Cardiac Robotic Navigation’s 7th Annual Meeting, which will take place October 19-20 in Washington, DC. The global physician-led Society for Cardiac Robotic Navigation (SCRN) is dedicated to establishing a community and platform for users of robotic technologies in card
- GlobeNewswire
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Heart Centre Rigshospitalet of Copenhagen University Hospital successfully treated the first patients using Stereotaxis’ Genesis Robotic Magnetic Navigation System. The Genesis system is the latest and most advanced robotic technology available for the treatment of heart rhythm disorders. Rigs
- GlobeNewswire
Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia Treatment
ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Overland Park Regional Medical Center (OPRMC) launched and successfully completed the first procedures using the advanced Genesis Robotic Magnetic Navigation (RMN) System. OPRMC – part of HCA Midwest Health, Kansas City’s largest healthcare provider – is the only hospital in the U.S. to offer t
